The Corus® CAD Gene Expression Test Addresses the Clinical Challenges Associated with the Evaluation of Women Presenting with Symptoms Suggestive of Obstructive Coronary Artery Disease by longitudeadmin | Jul 23, 2013 | Portfolio News
Esperion Therapeutics, Inc. Announces Exercise of Underwriters’ Over-Allotment Option for Initial Public Offering by longitudeadmin | Jul 11, 2013 | Portfolio News
Aptus Exceeds 250 Patients in ANCHOR Post-Market Registry by longitudeadmin | Jul 10, 2013 | Portfolio News
Esperion Therapeutics, Inc. Announces Pricing of Initial Public Offering by longitudeadmin | Jun 26, 2013 | Portfolio News
Rapid Micro Biosystems Secures $32.6 Million in Series B Financing by longitudeadmin | Jun 26, 2013 | Portfolio News
